Ranibizumab

Ranibizumab

Ranibizumab is an antibody fragment without the Fc portion and affinity-matured to more strongly bind VEGF-A

 

[accordions]
[accordion title= “Chemical Properties“]

 

Molecular Weight 48 kDa
CAS No. 347396-82-1

 

[/accordion]

 

 

[accordions]
[accordion title= “References and Literature“]

 

1. Klettner A, et al.Comparison of bevacizumab, ranibizumab, and pegaptanib in vitro: efficiency and possible additional pathways.Invest Ophthalmol Vis Sci. 2008 Oct;49(10):4523-7.

[/accordion]